Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53

United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$5.81M

$4.36M on a plan · $349.66K straight out of an exercise

Sold at will

$1.10M

2 of 36 sales

Net

−$5.81M

−$1.10M against sales at will